| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/06/1991 | US5037644 Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
| 08/06/1991 | CA1287300C Pharmaceutical composition containing taurolidine and/or taurultam |
| 08/04/1991 | WO1991011496A1 Novel vehicle gases and their use in medical preparations |
| 08/03/1991 | CA2035333A1 Sustained release with high and low viscosity hpmc |
| 08/02/1991 | CA2035385A1 Glycosyl prodrugs of anthracyclines, a process for the preparation thereof and the use thereof in combination with unctionalized tumor -specific enzyme conjugates |
| 08/01/1991 | DE4002736A1 Poly-amino-di:carboxylic acid co-anhydro-amino-di:carboxylic derivs. - bio:degradable polymeric peptide(s) for controlled release of pharmaceuticals |
| 08/01/1991 | DE4002257A1 Einkapselung von wirkstoffen mittels staerke Encapsulation of active ingredients by means strengthen people |
| 08/01/1991 | DE4001451A1 Stabile injizierbare loesungen von faktor viii und faktor ix Stable injectable loesungen of factor viii and ix factor |
| 08/01/1991 | CA2035279A1 Biologically degradable polymers, process for their preparation and use thereof for depot preparations having controlled delivery of active compound |
| 07/31/1991 | WO1991011176A1 Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances |
| 07/31/1991 | EP0439430A2 Transdermal administration of zwitterionic drugs |
| 07/31/1991 | EP0439344A2 Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
| 07/31/1991 | EP0439335A1 Topical composition |
| 07/31/1991 | EP0439095A2 Therapeutic antibody based fusion proteins |
| 07/31/1991 | EP0439042A1 Use of pharmaceutical and cosmetic preparations with mixed micellen |
| 07/31/1991 | EP0439030A2 Oral dosage forms containing pimobendan |
| 07/31/1991 | EP0438903A2 Treatment of poisoning and compositions for use therein |
| 07/31/1991 | EP0438747A1 Stabilized composition of glycopeptide antibiotics |
| 07/31/1991 | EP0438426A1 Polylactide compositions. |
| 07/31/1991 | CA2069644A1 Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances |
| 07/30/1991 | US5036102 Extra-corporeal infusion into blood |
| 07/30/1991 | US5036100 Antiinflammatory |
| 07/30/1991 | US5036060 Antitumor agent, lyophilized formulation containing sodium chloride as excipient |
| 07/30/1991 | US5036050 Compositions containing thymopentin for topical treatment of skin disorders |
| 07/30/1991 | US5035899 Benzimidazole antiulcer agents, protective coatings on tablets, stabilization |
| 07/30/1991 | US5035895 Vitamins, phosphatides, polyhydric alcohol, amino acid |
| 07/30/1991 | US5035894 Controlled release compositions and transdermal drug delivery device |
| 07/30/1991 | CA1286992C Pharmaceutical composition with analgesic activity |
| 07/27/1991 | WO1991011461A1 C4 binding protein fusion proteins |
| 07/27/1991 | WO1991011187A1 Pharmaceutical formulation |
| 07/27/1991 | WO1991011178A1 Encapsulation of active substances in starch |
| 07/27/1991 | CA2050599A1 Encapsulation of active substances in starch |
| 07/27/1991 | CA2049964A1 C4 binding protein fusion proteins |
| 07/26/1991 | CA2033714A1 Pharmaceutical preparations |
| 07/25/1991 | WO1991010696A1 Polyanhydrides of the oligomerized unsaturated aliphatic acids |
| 07/25/1991 | WO1991010667A1 Porphyrin derivatives and metalloporphyrins optionally coupled with a biologically active molecule, and pharmaceutical composition containing same |
| 07/25/1991 | WO1991010439A1 Stable injectible solutions for factor viii and factor ix |
| 07/25/1991 | WO1991010435A1 Chitosan pyrithione as antimicrobial agent useful in personal care products |
| 07/25/1991 | WO1991010426A1 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/25/1991 | WO1991008775A3 Maleic anhydride derivatives used as conjugation agents of anti-tumor agents on desired carriers |
| 07/24/1991 | EP0438259A1 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/24/1991 | EP0438249A1 Controlled absorption naproxen formulation for once-daily administration |
| 07/24/1991 | EP0438234A1 Antithrombin solution and use thereof |
| 07/24/1991 | EP0438183A1 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
| 07/24/1991 | EP0438147A2 Pharmaceutical compositions and dosage forms for the oral administration of calcitonin |
| 07/24/1991 | EP0438091A2 Freeze-dried preparation of etoposide-2-dimethylamino compound |
| 07/24/1991 | EP0437622A1 Stable motilin preparation |
| 07/24/1991 | EP0437621A1 Aqueous solution of motilin |
| 07/24/1991 | EP0437479A1 Method of making liposomes with improved stability during drying. |
| 07/24/1991 | EP0437478A1 Cyclodextrin-peptide complexes. |
| 07/24/1991 | CN1053185A Injectable solution and process for preparing same |
| 07/24/1991 | CN1053183A Stable oral zinc compound |
| 07/23/1991 | US5034506 Uncharged morpholino-based polymers having achiral intersubunit linkages |
| 07/23/1991 | US5034421 Release patterns for drugs bearing spun fibers |
| 07/23/1991 | US5034416 Carboxylic acid compositions |
| 07/23/1991 | US5034397 Stable, water soluble salt compositions of M-AMSA in 1-methyl-2-pyrrolidinone |
| 07/23/1991 | US5034386 Fungicides |
| 07/23/1991 | US5034379 Pharmaceutical formulation containing azapropazone |
| 07/23/1991 | US5034225 Stabilized human tissue plasminogen activator compositions |
| 07/23/1991 | US5034223 Antitumor agents |
| 07/23/1991 | US5034145 Polysiloxane or polyethersiloxane matrix for encapsulation of magnetizable particles |
| 07/23/1991 | CA2034516A1 Transdermal administration of zwitterionic drugs |
| 07/20/1991 | CA2034519A1 Pharmaceutical compositions and dosage forms for the oral administration of calcitonin |
| 07/20/1991 | CA2033680A1 Administration method of antithrombin |
| 07/18/1991 | WO1991010361A1 Composition to improve survival of biological materials |
| 07/17/1991 | WO1991010742A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins |
| 07/17/1991 | EP0437368A1 Fluid ophthalmic composition based on lipid microparticles containing at least one active principle |
| 07/17/1991 | EP0437225A1 Topical preparations |
| 07/17/1991 | EP0436960A1 Cosmetic or pharmaceutical formulations comprising crosslinked carboxylic copolymers useful as thickeners |
| 07/17/1991 | EP0436726A1 Method of photostabilizing eyewash |
| 07/17/1991 | EP0436667A1 Biodegradable in-situ forming implants. |
| 07/17/1991 | EP0436631A1 Method and composition for the treatment of burns. |
| 07/17/1991 | EP0436612A1 Amino acid transport proteins, amino acid analogues, assay apparatus, uses thereof for treatment and diagnosis of cancer |
| 07/17/1991 | EP0217920B1 Composition for delivery of orally administered substances |
| 07/17/1991 | EP0149600B1 Compositions for treating keratosis |
| 07/17/1991 | CN1053010A Pharmaceutical preparation |
| 07/17/1991 | CN1013196B Benzoyl urea compounds producing process |
| 07/17/1991 | CA2073060A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins |
| 07/16/1991 | US5032613 Method and composition for treating arthritis |
| 07/16/1991 | US5032582 Method for treating fungal infections with amphotericin B/cholesterol sulfate composition |
| 07/16/1991 | US5032572 Polymers containing cross-linked azo bonds, which polymers are useful for releasing therapeutic agents into the lower gastrointestinal tract |
| 07/16/1991 | US5032457 Anionic surfactants, zwitterions |
| 07/16/1991 | US5032408 Paraffin oil, glycerides, pancreas or thymus extreact, quaternized montmorillonite, preservative |
| 07/16/1991 | US5032406 Sustained release |
| 07/16/1991 | US5032403 Multilayer plaster |
| 07/16/1991 | US5032402 3-hydroxy-N-methylpyrrolidone and use as transdermal enhancer |
| 07/16/1991 | US5032401 Glucan drug delivery system and adjuvant |
| 07/16/1991 | US5032393 Ranitidine flavor masking |
| 07/16/1991 | CA1286229C Pseudoephedrine dosage form |
| 07/16/1991 | CA1286225C Medicament for the treatment of inflammations of the eye |
| 07/13/1991 | WO1991010422A1 Interdigitation-fusion liposomes and gels |
| 07/11/1991 | WO1991009958A2 Method of delivering molecules into eukaryotic cells |
| 07/11/1991 | WO1991009876A1 Radiolabeled proteins for diagnostic or therapeutic use |
| 07/11/1991 | WO1991009861A1 Sapphyrins, derivatives and synthesis |
| 07/11/1991 | WO1991009641A1 Fibrin sealant delivery method |
| 07/11/1991 | WO1991009634A1 Rolipram-containing composition for transdermal application |
| 07/11/1991 | WO1991009629A1 Liposomes as contrast agents for ultrasonic imaging |
| 07/11/1991 | WO1991009617A1 Insulin preparations containing nicotinic acid or nicotinamide |
| 07/11/1991 | WO1991009606A1 Freeze-dried dosage forms and methods for preparing the same |
| 07/11/1991 | WO1991009599A1 Smoking substitute |